Karolak, I.; Hrynkiewicz, R.; Niedźwiedzka-Rystwej, P.; Lechowicz, K.; Sieńko, J.; Szylińska, A.; Dabrowski, W.; Kotfis, K.
The Effect of Potassium Canrenoate (Mineralocorticoid Receptor Antagonist) on the Markers of Inflammation in the Treatment of COVID-19 Pneumonia and Fibrosis—A Secondary Analysis of Randomized Placebo-Controlled Clinical Trial. Int. J. Mol. Sci. 2023, 24, 14247.
https://doi.org/10.3390/ijms241814247
AMA Style
Karolak I, Hrynkiewicz R, Niedźwiedzka-Rystwej P, Lechowicz K, Sieńko J, Szylińska A, Dabrowski W, Kotfis K.
The Effect of Potassium Canrenoate (Mineralocorticoid Receptor Antagonist) on the Markers of Inflammation in the Treatment of COVID-19 Pneumonia and Fibrosis—A Secondary Analysis of Randomized Placebo-Controlled Clinical Trial. International Journal of Molecular Sciences. 2023; 24(18):14247.
https://doi.org/10.3390/ijms241814247
Chicago/Turabian Style
Karolak, Igor, Rafał Hrynkiewicz, Paulina Niedźwiedzka-Rystwej, Kacper Lechowicz, Jerzy Sieńko, Aleksandra Szylińska, Wojciech Dabrowski, and Katarzyna Kotfis.
2023. "The Effect of Potassium Canrenoate (Mineralocorticoid Receptor Antagonist) on the Markers of Inflammation in the Treatment of COVID-19 Pneumonia and Fibrosis—A Secondary Analysis of Randomized Placebo-Controlled Clinical Trial" International Journal of Molecular Sciences 24, no. 18: 14247.
https://doi.org/10.3390/ijms241814247
APA Style
Karolak, I., Hrynkiewicz, R., Niedźwiedzka-Rystwej, P., Lechowicz, K., Sieńko, J., Szylińska, A., Dabrowski, W., & Kotfis, K.
(2023). The Effect of Potassium Canrenoate (Mineralocorticoid Receptor Antagonist) on the Markers of Inflammation in the Treatment of COVID-19 Pneumonia and Fibrosis—A Secondary Analysis of Randomized Placebo-Controlled Clinical Trial. International Journal of Molecular Sciences, 24(18), 14247.
https://doi.org/10.3390/ijms241814247
